Tag: Vaccine

The anti-vax movement is using growing hesitation around the coronavirus vaccine to attract more people

The anti-vax movement is using growing hesitation around the coronavirus vaccine to attract more people

In this May 4, 2020 photo from the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial receives an injection.
In this May 4, 2020 photo from the University of Maryland School of Medicine, the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial receives an injection.

Associated Press

  • Some recent surveys suggest Americans, especially young ones, are wary of a coronavirus vaccine.

  • The anti-vaccine movement is capitalizing on this skepticism, including at a recent in-person conference held in North Carolina. 

  • Top scientific experts have said an effective, widely-used vaccine is the “only hope” at eliminating the coronavirus and achieving herd immunity quickly. 

  • Visit Business Insider’s homepage for more stories.

As scientists around the world race to develop a vaccine to fight the novel coronavirus, some Americans are still skeptical. 

A poll published May 27 found that only about half of Americans would get a coronavirus vaccine, should one become available, while 31% were unsure. One in five said they’d flat-out refuse, according the poll of 1,056 adults from

Read More
Vaccine and coronavirus skeptics packed into a hotel for a conference over Memorial Day weekend, defying guidelines

Vaccine and coronavirus skeptics packed into a hotel for a conference over Memorial Day weekend, defying guidelines

Homeopathic practitioner Robert Bell speaks at the Advanced Medicine Conference.
Homeopathic practitioner Robert Bell speaks at the Advanced Medicine Conference.

Andie Rea

  • About 200 vaccine and coronavirus skeptics gathered in a North Carolina hotel for a conference over Memorial Day weekend. 

  • Attendees did not wear masks, practice social distancing, or heed the governor’s guidelines to limit gatherings to 10 people. 

  • The hotel ended up calling the local police to help enforce social distancing policies.  

  • Visit Business Insider’s homepage for more stories.

As many Americans weighed the risks of going to the beach and backyard barbecues over Memorial Day weekend, hundreds of coronavirus and vaccine skeptics gathered in a Charlotte, North Carolina, hotel. 

“The Advanced Medicine Conference” attracted about 200 nonconventional medicine practitioners, researchers, anti-vaccine advocates, and members of the public, based on the best estimates of Business Insider Today, which sent a videographer to help conduct interviews.

Very few attendees wore masks, and the group didn’t comply with local guidelines

Read More
Coronavirus restrictions ease across America

Dow surges over 900 points amid coronavirus vaccine progress as lockdowns ease

U.S. equity markets soared Monday after drugmaker Moderna announced progress toward a COVID-19 vaccine and as lockdowns continued to ease nationwide.

The Dow Jones Industrial Average gained as many as 1,023 points before paring its advance in the final hour of trading.

The S&P 500 registered its best day since early April, rising 3.15 percent, while the Nasdaq Composite climbed 2.44 percent.

Investors also reacted favorably to Federal Reserve Chairman Jerome Powell, who said the central bank will continue to support the U.S. economy for as long as necessary.

Powell also warned that while the U.S. economy will return to growth in 2020, it may not reach pre-crisis levels until late next year and that a full recovery may hinge on the discovery of a COVID-19 vaccine.

TEXAS FEARS LOSING OIL-RICH LANDS IN CHINESE TAKEOVER OF WEAKENED ENERGY COMPANIES

“For the economy to fully recover, people will have to be

Read More
President says he has been taking hydroxychloroquine for weeks after insisting coronavirus vaccine announcement coming soon

President says he has been taking hydroxychloroquine for weeks after insisting coronavirus vaccine announcement coming soon

REUTERS
REUTERS

Donald Trump claims he takes a daily pill of the controversial drug hydroxychloroquine “as a preventative” against coronavirus, despite no evidence that links the anti-malaria drug as a preventative medicine to combat Covid-19 infection. “What do you have to lose?” he told reporters on Monday.

The president also attacked his predecessor Barack Obama for his criticism of the Trump administration’s response to the coronavirus, saying the 44th president was “grossly incompetent” in office, despite Mr Trump overseeing the deaths of nearly 90,0000 Americans during the outbreak.

While the former president has kept a dignified silence for much of his successor’s tenure, Mr Obama’s recent return to the limelight to endorse Joe Biden as the 2020 Democratic presidential nominee has seen the president whip up a spurious conspiracy theory involving Obama officials, the FBI and attempts to entrap Mr Trump’s incoming administration in 2017.

Eric Trump, the president’s son, has

Read More
India faces spike in coronavirus cases, says study, in test for health system

Who will get a coronavirus vaccine first? Here’s what experts say

As dozens of companies and universities rush to develop a coronavirus vaccine, the U.S. will also have to grapple with who will get a vaccine first once it’s been approved by the Food and Drug Administration.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices has historically made decisions on who is first to be immunized and whom the vaccine works best for, USA Today reported. The ACIP issues guidelines on whom vaccines should be distributed to, and how and when they get it.

“It’s inevitable that the vaccine will come out more slowly than we like. We’re not going to have 350 million doses delivered day one,” Andrew Pavia, chief of pediatric infectious diseases at the University of Utah, told USA Today.

Experts say the vaccine may be first given to the people most at risk of contracting the coronavirus or developing serious symptoms if infected.

Read More
Big buzz about Moderna's small vaccine test; Donald Trump threatens WHO funding; US deaths top 90K

Big buzz about Moderna’s small vaccine test; Donald Trump threatens WHO funding; US deaths top 90K

Pharmaceutical company Moderna announced positive results on Monday from the early stages of its trial for a potential vaccine and said it would continue on with the next stages.

Meanwhile, Secretary of Health and Human Services Alex Azar blasted the World Health Organization Monday during its two-day assembly. The WHO and China signaled support for an investigation into the handling of the response to the coronavirus pandemic in the early days of the outbreak. Appearing by video link, Azar criticized the WHO’s failures, saying it had cost “many lives.”

The U.S. has the largest coronavirus outbreak in the world by far. There are more than 90,000 deaths and almost 1.5 million confirmed cases, according to the Johns Hopkins University data dashboard. Worldwide, the virus has killed more than 317,000 people and has infected more than 4.7 million.

Our live blog is being updated throughout the day. Refresh for the latest

Read More
The Race to Develop a COVID-19 Vaccine, Explained

The Race to Develop a COVID-19 Vaccine, Explained

Imagine, if you can, life as it was a few months ago. Shopping for groceries without nervously eyeing anyone who creeps within six feet of you. Sitting down for dinner at a restaurant and actually enjoying the crowd. Watching live sports. These ho-hum aspects of everyday life are now the stuff of fantasy, reminders of a way of life the world is growing more and more desperate to reclaim. A beer in a bar with a friend feels as exotic as a daiquiri on a South Pacific beach.

A more pressing fantasy to fulfill is the one in which hundreds of Americans aren’t dying on a daily basis from a virus the scientific community still doesn’t fully understand. Unlike some other nations, the U.S. has been unable to contain the spread of the virus, which means the development of a vaccine is likely the only way to reclaim any semblance Read More

Moncef Slaoui, ex-pharma exec tapped by Trump to lead vaccine group, will divest $10M stock options

Moncef Slaoui, ex-pharma exec tapped by Trump to lead vaccine group, will divest $10M stock options

The former pharmaceutical executive tapped last week to head Operation Warp Speed, the White House group working to secure a coronavirus vaccine, will divest $10 million in stock options from a company considered one of the front-runners in the race to a vaccine.  

Last Wednesday Moncef Slaoui was named to head Operation Warp Speed. Slaoui had been on the board of the biotech company Moderna but resigned when his appointment to the White House position was announced. However, he still owned stock options in the company worth more than $10 million, according to the U.S. Securities and Exchange Commission. 

On Monday, Moderna announced promising though very preliminary results from a trial of its vaccine candidate in eight people. Moderna shares rose more than 20% on the news. The company’s stock has more than tripled in value in 2020.

Moncef Slaoui was tapped by the White House to lead its Operation Warp Speed, meant to coordinate efforts to find and distribute a coronavirus vaccine.
Moncef Slaoui was tapped by the White House to lead its Operation
Read More
Scientists warn Oxford vaccine may only offer ‘partial protection’ after results of monkey trial

Scientists warn Oxford vaccine may only offer ‘partial protection’ after results of monkey trial

Scientists have cast doubts over the coronavirus vaccine being developed by University of Oxford researchers, suggesting “concerning” results of trials in macaque monkeys indicated it may only offer “partial protection”.

The government pledged a further £65.5m for the research on Sunday, announcing it had struck a global licensing deal with pharmaceutical giant AstraZeneca, which will see up to 30 million doses produced by September if the vaccine is successful.

Human trials of the ChAdOx1 nCoV-19 vaccine are already underway, after trials on mice and rhesus macaques at the US National Institute of Health’s Rocky Mountain Laboratory, the full results of which were made public last week in a non-peer-reviewed preprint.

The researchers found a single dose of the vaccine prevented all six vaccinated monkeys from developing pneumonia, but did not prevent infection outright.

Some scientists not involved in the study welcomed the results as promising, but others also raised concerns

Read More
Coronavirus vaccine could come this year, Trump says. Experts say he needs a 'miracle' to be right.

Coronavirus vaccine could come this year, Trump says. Experts say he needs a ‘miracle’ to be right.

President Donald Trump has suggested multiple times that a coronavirus vaccine could come within months, an accelerated timeline that prominent health experts and veteran vaccine developers say is unlikely absent a miracle.

“We’re looking to get it by the end of the year if we can, maybe before,” Trump said Friday during in a Rose Garden event centered on his administration’s efforts to fast-track a vaccine.

“Vaccine work is looking VERY promising, before end of year,” Trump tweeted on Thursday.

“I think we’re going to have a vaccine by the end of the year,” he told reporters later in the day.

But experts say that the development, testing and production of a vaccine for

Read More